-0.22% Change Percent:
$58.64 Previous Close:
05/27/2020 04:56:19 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
|Stock Date||Open Price||Close Price||High||Low||Volume|
Deciphera Pharmaceuticals Inc. Company Name:
DCPH Stock Symbol:
News, Short Squeeze, Breakout and More Instantly...
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a commercial biopharmaceutical company addressing key mechanisms of tumor drug resistance, today announced that Steve Hoerter, President and Chief Executive Officer, will present at the Jefferies 2020 Healthcare Conference on Wednesday, June 3, 2...
Deciphera Pharmaceuticals (NASDAQ: DCPH) , a biopharmaceutical company based in Waltham, Mass., received a double shot of good news last week ... and has been climbing ever since. As of midday Friday, the biopharma's stock is now nearly $8 higher than it was at the end of the previous week -...
Deciphera Receives FDA Approval for GIST Therapy Deciphera Pharmaceuticals ( DCPH ) reported that it has received an early FDA approval for Qinlock for treating patients with gastrointestinal stromal tumor (GIST). The treatment is specifically targeted at patients who did not response to...